Chris Marcus, founder of Arcadia Economics, shares his thoughts on silver and gold. While it’s impossible to know exactly how precious metals prices will move in the short term, he’s confident they will maintain an…
-
-
Peter Schiff, chief economist and global strategist at Euro Pacific Asset Management and founder of Schiff Gold, shares his outlook on gold and silver prices. He also discusses Bitcoin and emerging markets. Securities Disclosure: I,…
-
Investor Insight With strategic, US-based assets, Trigg Minerals is well-positioned to become a cornerstone supplier of antimony and tungsten into the United States and allied markets. With a sharpened focus on critical minerals in Tier-1…
-
Investor Insight Australia’s ongoing energy supply challenges continue to highlight the need for innovative, low-carbon energy solutions. BPH Energy’s strategic investments in natural gas, hydrogen and emerging technologies position it to participate in this transition…
-
ReeXploration (TSXV:REE,FSE:KSi) is a discovery-focused critical minerals company advancing the Eureka rare earths project in Namibia. Strategically positioned, it taps into surging demand for critical minerals and the global push to diversify supply chains beyond…
-
Investor Insight ReeXploration offers investors early exposure to the global build-out of secure, Western-aligned critical minerals supply chains. Leveraging proven metallurgy and discovery upside at its high-grade Eureka project in Namibia, the company delivers a…
-
Is gold’s price pullback a buying opportunity, or the end of its run? Omar Ayales of Gold Charts R Us weighs in, saying either scenario is possible. He’s watching factors like the US dollar’s performance…
-
Jordan Roy-Byrne, CMT, MFTA, editor and publisher of the Daily Gold, discusses how long the gold and silver correction could last, and how high prices could go once it’s over. ‘We’re in a new secular…
-
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the US economy. ‘We’ve entered an era of what I call permanent inflation,’ he explained. ‘After World War II, inflation became permanent…
-
Investing
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact science with reduced financing risk.…